Loading clinical trials...
Loading clinical trials...
The investigators will evaluate the feasibility of implementing a low-intensity, patient-centered activity regimen (PCAR) that prioritizes education and communication over a 12-week period in advanced...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Yale University
Collaborators
NCT04973293 · Lung Neoplasm Malignant
NCT05241873 · Lung Neoplasm Malignant, Carcinoma, Non-Small-Cell Lung, and more
NCT05404022 · Lung Neoplasm Malignant, Mesothelioma; Lung
NCT04036721 · Lung Neoplasm Malignant, Interstitial Lung Disease
NCT05414188 · Lung Neoplasm Malignant
Yale University
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions